"Designing Growth Strategies is in our DNA"

Multiple Myeloma Market Size, Share & Industry Analysis, By Drug Class (Immunomodulators, Proteasome Inhibitor, Anti-CD38 Monoclonal Antibody, Alkylating Agents, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies), and Regional Forecast, 2019-2032

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI102693

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Multiple Myeloma - by Key Countries - 2018
    2. Pipeline Analysis
    3. Key Industry Developments
    4. Regulatory Scenario, by Key Regions
    5. Analysis Of Economic Burden of Multiple Myeloma Treatment
    6. New Product Launches
    7. Overview of Emerging Treatments for Multiple Myeloma
  5. Global Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Immunomodulators
      2. Proteasome Inhibitor
      3. Anti-CD38 Monoclonal Antibody
      4. Alkylating Agents
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Immunomodulators
      2. Proteasome Inhibitor
      3. Anti-CD38 Monoclonal Antibody
      4. Alkylating Agents
      5. Others
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    4. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Immunomodulators
      2. Proteasome Inhibitor
      3. Anti-CD38 Monoclonal Antibody
      4. Alkylating Agents
      5. Others
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    4. Market Analysis – By Country/ sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia pacific Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Immunomodulators
      2. Proteasome Inhibitor
      3. Anti-CD38 Monoclonal Antibody
      4. Alkylating Agents
      5. Others
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    4. Market Analysis – By Country/ sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Immunomodulators
      2. Proteasome Inhibitor
      3. Anti-CD38 Monoclonal Antibody
      4. Alkylating Agents
      5. Others
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    4. Market Analysis – By Country/ sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Immunomodulators
      2. Proteasome Inhibitor
      3. Anti-CD38 Monoclonal Antibody
      4. Alkylating Agents
      5. Others
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    4. Market Analysis – By Country/ sub-region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2017)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Takeda Pharmaceutical Company Limited
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Novartis AG
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Teva Pharmaceutical Industries Ltd.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Bristol Myers Squibb Company
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. Amgen Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. ONO PHARMACEUTICAL CO., LTD.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Janssen Pharmaceuticals, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Genentech, Inc. (F. Hoffmann-La Roche Ltd)
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. CELGENE CORPORATION (Bristol Myers Squibb Company)
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      10. AbbVie Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      11. Sanofi
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      12. Other Prominent Players
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  12. Strategic Recommendation
Read Less

Figure 1:  Global Multiple Myeloma Market Revenue Breakdown (US$ Bn, %) by Region, 2018 & 2026

Figure 2:  Global Multiple Myeloma Market Value Share (%), by Drug Class, 2018 & 2026

Figure 3:  Global Multiple Myeloma Market Forecast (US$ Bn), by Immunomodulators, 2015-2026

Figure 4:  Global Multiple Myeloma Market Forecast (US$ Bn), by Proteasome Inhibitor, 2015-2026

Figure 5:  Global Multiple Myeloma Market Forecast (US$ Bn), by Anti-CD38 Monoclonal Antibody, 2015-2026

Figure 6:  Global Multiple Myeloma Market Forecast (US$ Bn), by Alkylating Agents, 2015-2026

Figure 7:  Global Multiple Myeloma Market Forecast (US$ Bn), by Others, 2015-2026

Figure 8:  Global Multiple Myeloma Market Value Share (%), by Distribution Channel, 2018 & 2026

Figure 9:  Global Multiple Myeloma Market Forecast (US$ Bn), by Hospital Pharmacies, 2015-2026

Figure 10:  Global Multiple Myeloma Market Forecast (US$ Bn), by Retail Pharmacies & Drug Stores, 2015-2026

Figure 11:  Global Multiple Myeloma Market Forecast (US$ Bn), by Online Pharmacies, 2015-2026

Figure 12:  Global Multiple Myeloma Market Value (US$ Bn), by Region, 2018 & 2026

Figure 13:  North America Multiple Myeloma Market Value (US$ Bn), by Drug Class, 2018 & 2026

Figure 14:  North America Multiple Myeloma Market Value Share (%), by Drug Class, 2018

Figure 15:  North America Multiple Myeloma Market Value (US$ Bn), by Distribution Channel, 2018 & 2026

Figure 16:  North America Multiple Myeloma Market Value Share (%), by Distribution Channel, 2018

Figure 17:  North America Multiple Myeloma Market Value (US$ Bn), By Country, 2018 & 2026

Figure 18:  North America Multiple Myeloma Market Value Share (%), By Country, 2018

Figure 19:  Europe Multiple Myeloma Market Value (US$ Bn), by Drug Class, 2018 & 2026

Figure 20:  Europe Multiple Myeloma Market Value Share (%), by Drug Class, 2018

Figure 21:  Europe Multiple Myeloma Market Value (US$ Bn), by Distribution Channel, 2018 & 2026

Figure 22:  Europe Multiple Myeloma Market Value Share (%), by Distribution Channel, 2018

Figure 23:  Europe Multiple Myeloma Market Value (US$ Bn), By Country/ Sub-region, 2018 & 2026

Figure 24:  Europe Multiple Myeloma Market Value Share (%), By Country/ Sub-region, 2018

Figure 25:  Asia Pacific Multiple Myeloma Market Value (US$ Bn), by Drug Class, 2018 & 2026

Figure 26:  Asia Pacific Multiple Myeloma Market Value Share (%), by Drug Class, 2018

Figure 27:  Asia Pacific Multiple Myeloma Market Value (US$ Bn), by Distribution Channel, 2018 & 2026

Figure 28:  Asia Pacific Multiple Myeloma Market Value Share (%), by Distribution Channel, 2018

Figure 29:  Asia Pacific Multiple Myeloma Market Value (US$ Bn), By Country/ Sub-region, 2018 & 2026

Figure 30:  Asia Pacific Multiple Myeloma Market Value Share (%), By Country/ Sub-region, 2018

Figure 31:  Latin America Multiple Myeloma Market Value (US$ Bn), by Drug Class, 2018 & 2026

Figure 32:  Latin America Multiple Myeloma Market Value Share (%), by Drug Class, 2018

Figure 33:  Latin America Multiple Myeloma Market Value (US$ Bn), by Distribution Channel, 2018 & 2026

Figure 34:  Latin America Multiple Myeloma Market Value Share (%), by Distribution Channel, 2018

Figure 35:  Latin America Multiple Myeloma Market Value (US$ Bn), By Country/ Sub-region, 2018 & 2026

Figure 36:  Latin America Multiple Myeloma Market Value Share (%), By Country/ Sub-region, 2018

Figure 37:  Middle East & Africa Multiple Myeloma Market Value (US$ Bn), by Drug Class, 2018 & 2026

Figure 38:  Middle East & Africa Multiple Myeloma Market Value Share (%), by Drug Class, 2018

Figure 39:  Middle East & Africa Multiple Myeloma Market Value (US$ Bn), by Distribution Channel, 2018 & 2026

Figure 40:  Middle East & Africa Multiple Myeloma Market Value Share (%), by Distribution Channel, 2018

Figure 41:  Middle East & Africa Multiple Myeloma Market Value (US$ Bn), By Country/ Sub-region, 2018 & 2026

Figure 42:  Middle East & Africa Multiple Myeloma Market Value Share (%), By Country/ Sub-region, 2018

Figure 43:  Global Multiple Myeloma Market Share (%), By Company, 2018

Table 1:  Global Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Drug Class, 2015–2026

Table 2:  Global Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2015–2026

Table 3:  Global Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Region, 2015-2026

Table 4:  North America Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Drug Class, 2015-2026

Table 5:  North America Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2015-2026

Table 6:  North America Multiple Myeloma Market Revenue (US$ Bn) Forecast, By Country, 2015-2026

Table 7:  Europe Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Drug Class, 2015-2026

Table 8:  Europe Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2015-2026

Table 9:  Europe Multiple Myeloma Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2015-2026

Table 10:  Asia Pacific Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Drug Class, 2015-2026

Table 11:  Asia Pacific Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2015-2026

Table 12:  Asia Pacific Multiple Myeloma Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2015-2026

Table 13:  Latin America Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Drug Class, 2015-2026

Table 14:  Latin America Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2015-2026

Table 15:  Latin America Multiple Myeloma Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2015-2026

Table 16:  Middle East & Africa Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Drug Class, 2015-2026

Table 17:  Middle East & Africa Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2015-2026

Table 18:  Middle East & Africa Multiple Myeloma Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2015-2026

Multiple Myeloma Market Size, Share and Global Industry Trend Forecast till 2032
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Consulting Services
    How will you benefit from our consulting services ?